Flurox is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Ocusoft, Inc.. The primary component is Fluorescein Sodium; Benoxinate Hydrochloride.
Product ID | 54799-508_5476a07b-4f5c-3b6b-38b3-b006435306c1 |
NDC | 54799-508 |
Product Type | Human Prescription Drug |
Proprietary Name | Flurox |
Generic Name | Fluorescein Sodium 2.5mg (0.25%), Benoxinate Hydrochloride 4mg (0.4%) |
Dosage Form | Solution |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2014-01-29 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | OCuSOFT, Inc. |
Substance Name | FLUORESCEIN SODIUM; BENOXINATE HYDROCHLORIDE |
Active Ingredient Strength | 3 mg/mL; mg/mL |
Pharm Classes | Diagnostic Dye [EPC],Dyes [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-01-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-01-29 |
Marketing End Date | 2018-02-08 |
Ingredient | Strength |
---|---|
FLUORESCEIN SODIUM | 2.5 mg/mL |
SPL SET ID: | 900ec4c1-e5e3-e940-5b02-cf2589955e20 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FLUROX 90051587 not registered Live/Pending |
OCuSOFT, Inc. 2020-07-14 |